Results 31 to 40 of about 2,041,012 (194)

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study

open access: yesFrontiers in Oncology, 2023
ObjectiveTo report the incidence of radiation pneumonitis after radioembolization.MethodsIn this retrospective study, from May 2009 to July 2021, 782 consecutive patients underwent radioembolization in two institutes.
Hyo-Cheol Kim, Gyoung Min Kim
doaj   +1 more source

Structure of Yttrium and Phosphorus-Containing Microspheres Prepared by Spray Dry Method [PDF]

open access: yes, 2013
Microspheres containing yttrium (Y) and/or phosphorus (P) around 25 µm are useful for radioembolization therapy because they are activated to β-emitter by neutron bombardment and infused in blood vessels in the neighborhood of tumors to irradiateβ-rays ...
17156   +13 more
core   +5 more sources

Efficacy and Safety Of Radiation Synovectomy with Yttrium-90 [PDF]

open access: yes, 1993
In this long term retrospective study of radiation synovectomy with Yttrium-90 (Y90), we evaluated the results of 164 applications in 82 patients with RA, OA with synovitis, ankylosing spondylitis and psoriatic arthritis.
Stucki, Gerold   +4 more
core   +1 more source

Trans-arterial hepatic radioembolisation of yttrium-90 microspheres

open access: yesBiomedical Imaging and Intervention Journal, 2006
The liver represents a frequent site for metastatic disease, in addition to being a site for primary cancer. Hepatic metastases from certain neoplasms, such as colon, neuroendocrine, melanoma and gastrointestinal stromal tumour have a distinct predilection to metastasize the liver, which in many cases may represent the only or the dominant site of ...
Murthy, R, Habbu, A, Salem, R
openaire   +2 more sources

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients

open access: yesTranslational Oncology, 2014
Transarterial radioembolization (TARE) with 90Y microspheres delivers low dose rate radiation (LDR) to intrahepatic tumors. In the current study, we examined clonogenic survival, DNA damage, and cell cycle distribution in hepatocellular carcinoma (HCC ...
Kyle C. Cuneo   +5 more
doaj   +1 more source

Chemorefractory liver metastasis from cervical cancer successfully treated with a combination of yttrium-90 and immunotherapy

open access: yesRadiology Case Reports, 2020
Liver metastases in cervical cancer is rare and can be difficult-to-treat. The current guidelines established by the Gynecologic Oncology Group recommend platinum-based systemic chemotherapy in combination with an anti-angiogenic agent such as ...
Michael E. Nance   +3 more
doaj   +1 more source

Effects of hepatic arterial yttrium 90 glass microspheres in dogs [PDF]

open access: yesCancer, 1988
A 22-micron glass microsphere called TheraSphere (Theragenics Corp., Atlanta, GA) has been developed in which yttrium 89 oxide is incorporated into the glass matrix and is activated by neutron bombardment to form the beta-emitting isotope yttrium 90 (Y 90) before using the spheres as radiotherapeutic vehicles.
Ira Wollner   +10 more
openaire   +2 more sources

Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionuclide therapy [PDF]

open access: yes, 2013
Internal dosimetry of non-uniform activity distributions: a simple method for the calculation of the absorbed dose distribution at voxel level in radionulcide therapy Radiotherapy is the medical use of ionizing radiations to control or kill clonogenic ...
AVIGO, CINZIA
core   +1 more source

Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports

open access: yesEinstein (São Paulo), 2020
Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho   +9 more
doaj   +2 more sources

Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas

open access: yesCurrent Oncology, 2021
Background: In the Yttrium-90 Microspheres in Cholangiocarcinoma (MISPHEC) single-arm phase 2 trial, concomitant chemotherapy and selective internal radiotherapy (SIRT) showed antitumor activity as a first-line treatment of unresectable intrahepatic ...
Camille Goislard de Monsabert   +16 more
doaj   +1 more source

Home - About - Disclaimer - Privacy